Novartis Injects Street Theatre Into London Vet Show

Man in a box and animal performers entertain veterinarians at the London Vet Show Novartis injected some theatre into this year’s London Vet Show surprising visitors with its man in a box and animal ‘street’ performers. The characters were raising awareness of the company’s non-steroidal anti-inflammatory drug, Onsior®. Veterinary surgeons were directed to the Novartis stand where they had the chance to win an iPad3. A recent published clinical study demonstrated Onsior® Injection had superior efficacy to meloxicam injection in reducing post-operative pain in cats.1 More information can be found at www.onsior-relief.co.uk. Kamata M, King J, Seewald W et al. The Veterinary Journal, 2012, vol 193 (1). Comparison of single injection of robenacoxib (2mg/kg) versus single injection of metoxican (0.3 mg/k/g)Onsior® (robenacoxib) is a registered trademark of Novartis AG, Basel, Switzerland. © 2012 Novartis Animal Health UK Ltd

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards